Search arXivSearch

arXiv · 2511.00278

SCUDDO: An unsupervised clustering algorithm for single-cell Hi-C maps using diagonal diffusion operators

Abstract

Motivation: Advances in high-throughput chromatin conformation capture have provided insight into the three-dimensional structure and organization of chromatin. While bulk Hi-C experiments capture spatio-temporally averaged chromatin interactions across millions of cells, single-cell Hi-C experiments report on the chromatin interactions of individual cells. Supervised and unsupervised algorithms have been developed to embed single-cell Hi-C maps and identify different cell types. However, single-cell Hi-C maps are often difficult to cluster due to their high sparsity, with state-of-the-art algorithms achieving a maximum Adjusted Rand Index (ARI) of only < 0.4 on several datasets while requiring labels for training. Results: We introduce a novel unsupervised algorithm, Single-cell Clustering Using Diagonal Diffusion Operators (SCUDDO), to embed and cluster single-cell Hi-C maps. We evaluate SCUDDO on three previously difficult-to-cluster single-cell Hi-C datasets, and show that it can outperform other current algorithms in ARI by > 0.2. Further, SCUDDO outperforms all other tested algorithms even when we restrict the number of intrachromosomal maps for each cell type and when we use only a small fraction of contacts in each Hi-C map. Thus, SCUDDO can capture the underlying latent features of single-cell Hi-C maps and provide accurate labeling of cell types even when cell types are not known a priori. Availability: SCUDDO is freely available at www.github.com/lmaisuradze/scuddo. The tested datasets are publicly available and can be downloaded from the Gene Expression Omnibus.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Luka Maisuradze, Corey S. O'Hern, Mark D. Shattuck. 2025-10-31. SCUDDO: An unsupervised clustering algorithm for single-cell Hi-C maps using diagonal diffusion operators. https://doi.org/10.1093/bioinformatics%2Fbtag284

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

Transcriptomic Models for Immunotherapy Response Prediction Show Limited Cross-cohort Generalisability

Immune checkpoint inhibitors (ICIs) have transformed cancer therapy; yet substantial proportion of patients exhibit intrinsic or acquired resistance, making accurate pre-treatment response prediction a critical unmet need. Transcriptomics-based biomarkers derived from bulk and single-cell RNA sequencing (scRNA-seq) offer a promising avenue for capturing tumour-immune interactions, yet the cross-cohort generalisability of existing prediction models remains unclear.We systematically benchmark nine state-of-the-art transcriptomic ICI response predictors, five bulk RNA-seq-based models (COMPASS, IRNet, NetBio, IKCScore, and TNBC-ICI) and four scRNA-seq-based models (PRECISE, DeepGeneX, Tres and scCURE), using publicly available independent datasets unseen during model development. Overall, predictive performance was modest: bulk RNA-seq models performed at or near chance level across most cohorts, while scRNA-seq models showed only marginal improvements. Pathway-level analyses revealed sparse and inconsistent biomarker signals across models. Although scRNA-seq-based predictors converged on immune-related programs such as allograft rejection, bulk RNA-seq-based models exhibited little reproducible overlap. PRECISE and NetBio identified the most coherent immune-related themes, whereas IRNet predominantly captured metabolic pathways weakly aligned with ICI biology. Together, these findings demonstrate the limited cross-cohort robustness and biological consistency of current transcriptomic ICI prediction models, underscoring the need for improved domain adaptation, standardised preprocessing, and biologically grounded model design.

q-bio.GN

Large Language Model Agents for Evidence Based Genetic Disease Severity Classification

Disease severity classification for genetic conditions is subjective and labor-intensive, creating bottlenecks in genomic screening, where commercial panels vary widely in size and overlap. We developed an autonomous AI agent integrating Reasoning and Acting (ReAct) with Retrieval-Augmented Generation (RAG) to classify 10,211 Human Phenotype Ontology terms. It uses American College of Medical Genetics (ACMG)-endorsed severity guidelines and American College of Obstetricians and Gynecologists (ACOG) quality-of-life criteria to retrieve PubMed literature, generate interpretable reasoning chains, and independently verify claims. At the phenotype level, using expert-curated cohorts, the agent achieved 93.55% accuracy (MCC 0.9237) with 82.6% to 91.4% of claims supported by direct evidence or valid inferences. Gene-level severity was aggregated across 8,738 pairs, identifying 3,283 autosomal recessive pairs with severe or profound presentations. External validation showed 95.2% concordance with Mackenzie's Mission gene list. This system enables standardized panel design by providing reliable, automated classification supported by direct evidence.

q-bio.GN

Harmonised benchmarking of foundation models for single-cell and spatial transcriptomics reveals context-dependent generalisation

Single-cell and spatial foundation models promise transferable biological representations, yet their generality remains largely untested across modalities, biological domains and analytical tasks. We benchmarked six representative models, Nicheformer, CellPLM, scGPT-spatial, GenePT, scELMo and Novae, using a harmonised framework spanning scRNA-seq, spatial transcriptomics and Perturb-seq. We evaluated zero-shot and continually pretrained clustering, supervised annotation, marker-gene concordance and perturbation prediction. Model performance was strongly conditional: expression-trained cell-level transformers best resolved many cell-identity tasks, spatial and graph-aware models better preserved tissue architecture, and language-derived gene embeddings were competitive for selected perturbation-response metrics. No model dominated across tasks, and rankings shifted with modality, preprocessing, tokenisation, biological prior, domain shift and metric choice. This benchmark provides practical guidance for model selection and argues that future models should be judged by biological generalisation, interpretability and perturbation-grounded validity, not by scale or leaderboard performance alone.

q-bio.GN